Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)
Phase 2
- Conditions
- Carcinoma of Unknown Primary Sites
- Registration Number
- JPRN-UMIN000001364
- Lead Sponsor
- Kyushu Medical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Massive pleural effusion or massive ascites (2)Symptomatic brain metastases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method